BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Lexicon Genetics Incorporated 

8800 Technology Forest Place

The Woodlands  Texas  77381  U.S.A.
Phone: 281-863-3000 Fax: 281-863-8088


SEARCH JOBS


Industry
Biotechnology

Segment
Genomics





 Company News
Lexicon Genetics Incorporated (LEXG) to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009 11/23/2009 9:32:21 AM    More...
Lexicon Genetics Incorporated (LEXG) Initiates Phase 2 Clinical Trial of LX2931 in Patients With Rheumatoid Arthritis 8/4/2009 7:58:07 AM    More...
Lexicon Genetics Incorporated (LEXG) Files Investigational New Drug Application for LX2931 as a Potential Treatment for Rheumatoid Arthritis 11/12/2007 8:05:59 AM    More...
Lexicon Genetics Incorporated (LEXG) to Present at the Biotechnology Industry Organization (BIO) 2007 International Convention 5/7/2007 1:50:26 PM    More...
Lexicon Genetics Incorporated (LEXG) Changes Name to Lexicon Pharmaceuticals as Drug Development Pipeline Progresses 4/26/2007 12:07:01 PM    More...
Lexicon Genetics Incorporated (LEXG) Advances LX1031 for Irritable Bowel Syndrome Into Phase 1b Clinical Trial 4/24/2007 12:31:28 PM    More...
Lexicon Genetics Incorporated (LEXG) to Present at the Morgan Stanley Global Healthcare Unplugged Conference 4/23/2007 11:59:44 AM    More...
Lexicon Genetics Incorporated (LEXG) to Report First Quarter 2007 Financial Results on May 1, 2007; Conference Call and Webcast to Follow 4/13/2007 11:42:28 AM    More...
Lexicon Genetics Incorporated (LEXG) Appoints Tamar Howson Executive Vice President of Business Development 3/21/2007 1:06:33 PM    More...
Lexicon Genetics Incorporated (LEXG) Elects Kathleen Wiltsey to Board of Directors 2/28/2007 11:06:36 AM    More...
12345678910...

//-->